CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351 | +20.6% | 12,876 | -1.7% | 0.02% | +36.4% |
| Q2 2023 | $291 | -24.6% | 13,099 | -26.6% | 0.01% | -31.2% |
| Q1 2023 | $386 | +6.0% | 17,842 | -0.3% | 0.02% | 0.0% |
| Q4 2022 | $364 | -99.9% | 17,904 | -17.2% | 0.02% | -27.3% |
| Q3 2022 | $555,000 | -14.5% | 21,636 | -20.8% | 0.02% | +15.8% |
| Q2 2022 | $649,000 | +5.7% | 27,304 | +0.2% | 0.02% | +35.7% |
| Q1 2022 | $614,000 | -0.8% | 27,256 | -12.9% | 0.01% | +7.7% |
| Q4 2021 | $619,000 | +1.0% | 31,287 | +0.5% | 0.01% | -7.1% |
| Q3 2021 | $613,000 | -14.1% | 31,137 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $714,000 | +23.1% | 32,477 | +33.3% | 0.01% | +16.7% |
| Q1 2021 | $580,000 | -9.5% | 24,371 | -0.6% | 0.01% | -7.7% |
| Q4 2020 | $641,000 | +50.1% | 24,511 | 0.0% | 0.01% | +30.0% |
| Q3 2020 | $427,000 | +3.6% | 24,511 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $412,000 | – | 24,511 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |